chr16-1202369-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021098.3(CACNA1H):​c.1919C>A​(p.Pro640Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000213 in 1,405,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P640A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.07

Publications

40 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12819034).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.1919C>Ap.Pro640Gln
missense
Exon 9 of 35NP_066921.2O95180-1
CACNA1H
NM_001005407.2
c.1919C>Ap.Pro640Gln
missense
Exon 9 of 34NP_001005407.1O95180-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.1919C>Ap.Pro640Gln
missense
Exon 9 of 35ENSP00000334198.7O95180-1
CACNA1H
ENST00000569107.6
TSL:1
c.1919C>Ap.Pro640Gln
missense
Exon 9 of 34ENSP00000454990.2H3BNT0
CACNA1H
ENST00000711493.1
c.1919C>Ap.Pro640Gln
missense
Exon 9 of 34ENSP00000518778.1A0AAA9YHG8

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
158394
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000213
AC:
3
AN:
1405398
Hom.:
0
Cov.:
60
AF XY:
0.00000144
AC XY:
1
AN XY:
694232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32020
American (AMR)
AF:
0.00
AC:
0
AN:
36780
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36240
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79478
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46776
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5704
European-Non Finnish (NFE)
AF:
0.00000277
AC:
3
AN:
1084944
Other (OTH)
AF:
0.00
AC:
0
AN:
58322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.00
Hom.:
6225
ExAC
AF:
0.0000282
AC:
3

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Uncertain
0.085
D
BayesDel_noAF
Benign
-0.12
CADD
Benign
14
DANN
Benign
0.86
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.65
T
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.13
T
MetaSVM
Uncertain
0.041
D
MutationAssessor
Benign
1.9
L
PhyloP100
1.1
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.25
Sift
Benign
0.32
T
Sift4G
Benign
0.26
T
Polyphen
0.010
B
Vest4
0.23
MutPred
0.19
Loss of glycosylation at P640 (P = 0.0742)
MVP
0.71
ClinPred
0.20
T
GERP RS
2.6
Varity_R
0.11
gMVP
0.33
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734410; hg19: chr16-1252369; API